BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2445635)

  • 21. Cisplatin, vinblastine and bleomycin in advanced and relapsed germ cell tumours of ovary.
    Kumar L; Bhargawa VL; Kumar S
    Asia Oceania J Obstet Gynaecol; 1993 Jun; 19(2):133-40. PubMed ID: 7691050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential trials of cisplatin, vinblastine, and bleomycin and etoposide and cisplatin in disseminated nonseminomatous germ cell tumors of the testis with a good prognosis at a single institution.
    Germá JR; Sagarra AF; Izquierdo MA; Seguí MA
    Cancer; 1993 Feb; 71(3):796-803. PubMed ID: 7679314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of VAB-6 combination chemotherapy on malignant germ cell tumours in childhood.
    Hayashi Y; Ohi R; Konno T; Tsuchiya S; Muraosa Y; Yaoita S; Watanabe T
    Z Kinderchir; 1989 Aug; 44(4):208-12. PubMed ID: 2477963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
    Bosl GJ; Geller NL; Bajorin D; Leitner SP; Yagoda A; Golbey RB; Scher H; Vogelzang NJ; Auman J; Carey R
    J Clin Oncol; 1988 Aug; 6(8):1231-8. PubMed ID: 2457657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.
    Ozols RF; Ihde DC; Linehan WM; Jacob J; Ostchega Y; Young RC
    J Clin Oncol; 1988 Jun; 6(6):1031-40. PubMed ID: 2453619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support.
    Broun ER; Nichols CR; Turns M; Williams SD; Loehrer PJ; Roth BJ; Lazarus HM; Einhorn LH
    Cancer; 1994 Mar; 73(6):1716-20. PubMed ID: 7512438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group.
    Levi JA; Raghavan D; Harvey V; Thompson D; Sandeman T; Gill G; Stuart-Harris R; Snyder R; Byrne M; Kerestes Z
    J Clin Oncol; 1993 Jul; 11(7):1300-5. PubMed ID: 7686216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
    Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U
    Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cisplatin, vinblastine and bleomycin (PVB) combination chemotherapy in the treatment of intracranial malignant germ cell tumors--a preliminary report of a phase II study--The Japanese Intracranial Germ Cell Tumor Study Group].
    Matsukado Y; Abe H; Tanaka R; Kobayashi T; Yamashita J; Nishimoto A; Ushio Y; Sato K; Matsutani M; Takakura K
    Gan No Rinsho; 1986 Sep; 32(11):1387-93. PubMed ID: 2430119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.
    Logothetis CJ; Samuels ML; Selig D; Swanson D; Johnson DE; von Eschenbach AC
    J Clin Oncol; 1985 Mar; 3(3):326-35. PubMed ID: 2579213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose intensity and outcome with combination chemotherapy for germ cell carcinoma. Australasian Germ Cell Trial Group.
    Levi JA; Thomson D; Bishop J; Raghavan D; Tattersall M; Byrne M; Gill G; Harvey V; Snyder R; Dalley D
    Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1073-7. PubMed ID: 2474445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide.
    Williams SD; Birch R; Einhorn LH; Irwin L; Greco FA; Loehrer PJ
    N Engl J Med; 1987 Jun; 316(23):1435-40. PubMed ID: 2437455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient cortical blindness during chemotherapy (PVB) for ovarian germ cell tumor.
    Manchana T; Sirisabya N; Lertkhachonsuk R; Tresukosol D
    J Med Assoc Thai; 2006 Aug; 89(8):1265-8. PubMed ID: 17048439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Total remission of advanced cancer of the testis with the use of the VAB6 schedule: experience with 40 cases].
    Srougi M; Simon SD; de Góes GM
    AMB Rev Assoc Med Bras; 1985; 31(3-4):52-8. PubMed ID: 2417287
    [No Abstract]   [Full Text] [Related]  

  • 35. Neutropenia and fever in patients undergoing combination chemotherapy for malignant germ cell tumors of the ovary.
    Chambers SK; Schwartz PE
    Obstet Gynecol; 1986 Dec; 68(6):842-6. PubMed ID: 2431369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin.
    Gershenson DM; Morris M; Cangir A; Kavanagh JJ; Stringer CA; Edwards CL; Silva EG; Wharton JT
    J Clin Oncol; 1990 Apr; 8(4):715-20. PubMed ID: 1690272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination chemotherapy with cisplatin, vinblastine, and bleomycin for endodermal sinus tumor of the ovary.
    Davis TE; Loprinzi CL; Buchler DA
    Gynecol Oncol; 1984 Sep; 19(1):46-52. PubMed ID: 6205945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin.
    Vogelzang NJ; Torkelson JL; Kennedy BJ
    Cancer; 1985 Dec; 56(12):2765-70. PubMed ID: 2413982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular toxicity following vinblastine, bleomycin, and cisplatin therapy for germ cell tumours.
    Samuels BL; Vogelzang NJ; Kennedy BJ
    Int J Androl; 1987 Feb; 10(1):363-9. PubMed ID: 2438227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary.
    Culine S; Kattan J; Lhomme C; Duvillard P; Michel G; Castaigne D; Leclere J; Pico J; Droz JP
    Gynecol Oncol; 1994 Jul; 54(1):47-53. PubMed ID: 7517380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.